Kun-Ling Tsai

Dr. Kun-Ling Tsai

Department of Internal Medicine, National Cheng Kung University Hospital

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Pei-Ling HsiehPei-Ling Hsieh
Pei-Ling Hsieh
PCPei-Ming Chu
Pei-Ming Chu
HCHui-Ching Cheng
Hui-Ching Cheng
YHYu-Ting Huang
Yu-Ting Huang
WCWan-Ching Chou
Wan-Ching Chou
KTKun-Ling Tsai
Kun-Ling Tsai
Doxorubicin (Dox) is a commonly used anthracycline chemotherapy with a side effect of cardiotoxicity, which may increase the risk of heart failure for cancer patients. Although various studies have demonstrated the cardioprotective property of dapagliflozin (DAPA), a sodium-glucose cotransporter 2 inhibitor, the detailed mechanism underlying its effect on Dox-induced cardiomyopathy is still limited. In this study, we showed that DAPA induced the activation of AKT/PI3K signaling in cardiac myoblast H9c2 cells following Dox treatment, leading to the upregulation of antioxidant HO-1, NQO1, and SOD, as well as an improved mitochondrial dysfunction via Nrf2. In addition, the reduced oxidative stress resulted in the downregulation of hypertrophy (ANP and BNP) and fibrosis (phospho-Smad3, collagen I, fibronectin, and α-SMA) markers. Furthermore, the inflammatory IL-8 concentration was inhibited after DAPA, possibly through PI3K/AKT/Nrf2/p38/NF-κB signaling. Moreover, our results were validated in vivo, and echocardiography results suggested an improved cardiac function in DAPA-receiving rats. In summary, we demonstrated that the administration of DAPA could mitigate the Dox-elicited cardiotoxicity by reducing oxidative stress, mitochondrial dysfunction, fibrosis, hypertrophy, and inflammation via PI3K/AKT/Nrf2 signaling.

26 February 2021 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
KTKun-Ling Tsai
Kun-Ling Tsai
PHPei-Ling Hsieh
Pei-Ling Hsieh
WCWan-Ching Chou
Wan-Ching Chou
HCHui-Ching Cheng
Hui-Ching Cheng
YHYu-Ting Huang
Yu-Ting Huang
KTKun-Ling Tsai
Kun-Ling Tsai
Background: Emerging evidence demonstrated dapagliflozin (DAPA), a sodium-glucose cotransporter 2 inhibitor, prevented various cardiovascular events. However, the detailed mechanisms underlying its cardioprotective properties remained largely unknown. Results: In the present study, we sought to investigate the effects of DAPA on the cardiac ischemia/reperfusion (I/R) injury. Results from in vitro experiments showed that DAPA induced the phosphorylation of AMPK, resulting in the downregulation of PKC in the cardiac myoblast H9c2 cells following hypoxia/reoxygenation (H/R) condition. We demonstrated that DAPA treatment diminished the H/R-elicited oxidative stress via the AMPK/ PKC/ NADPH oxidase pathway. In addition, DAPA prevented the H/R-induced abnormality of PGC-1α expression, mitochondrial membrane potential, and mitochondrial DNA copy number through AMPK/ PKC/ NADPH oxidase signaling. Besides, DAPA reversed the H/R-induced apoptosis. Furthermore, we demonstrated that DAPA improved the I/R-induced cardiac dysfunction by echocardiography and abrogated the I/R-elicited apoptosis in the myocardium of rats. Also, the administration of DAPA mitigated the production of myocardial infarction markers. Conclusions: In conclusion, our data suggested that DAPA treatment holds the potential to ameliorate the I/R-elicited oxidative stress and the following cardiac apoptosis via modulation of AMPK, which attenuates the cardiac dysfunction caused by I/R injury.

9 April 2019 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
HOHsiu‐Chung Ou
Hsiu‐Chung Ou
WCWan‐Ching Chou
Wan‐Ching Chou
CHChing‐Hsia Hung
Ching‐Hsia Hung
PCPei‐Ming Chu
Pei‐Ming Chu
PHPei‐Ling Hsieh
Pei‐Ling Hsieh
KTKun-Ling Tsai
Kun-Ling Tsai

12 July 2012 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
KTKun-Ling Tsai
Kun-Ling Tsai
UKUshio Kikkawa
Ushio Kikkawa
HMHidenori Matsuzaki
Hidenori Matsuzaki
JCJyh-Hong Chen
Jyh-Hong Chen
Wei-Chiao ChangWei-Chiao Chang
Wei-Chiao Chang
Background: Insulin receptor substrate (IRS)-1 is associated with tumorigenesis; its levels are elevated in several human cancers. IRS-1 protein binds to several oncogene proteins. Oxidative stress and reactive oxygen species (ROS) are involved in the initiation and progression of cancers. Cancer cells produce greater levels of ROS than normal cells do because of increased metabolic stresses. However, excessive production of ROS kills cancer cells. Autophagy usually serves as a survival mechanism in response to stress conditions, but excessive induction of autophagy results in cell death. In addition to inducing necrosis and apoptosis, ROS induces autophagic cell death. ROS inactivates IRS-1 mediated signaling and reduces intracellular IRS-1 concentrations. Thus, there is a complex relationship between IRS-1, ROS, autophagy, and cancer. It is not fully understood how cancer cells grow rapidly and survive in the presence of high ROS levels. Methods and results: In this study, we established mouse NIH/3T3 cells that overexpressed IRS-1, so mimicking cancers with increased IRS-1 expression levels; we found that the IRS-1 overexpressing cells grow more rapidly than control cells do. Treatment of cells with glucose oxidase (GO) provided a continuous source of ROS; low dosages of GO promoted cell growth, while high doses induced cell death. Evidence for GO induced autophagy includes increased levels of isoform B-II microtubule-associated protein 1 light chain 3 (LC3), aggregation of green fluorescence protein-tagged LC3, and increased numbers of autophagic vacuoles in cells. Overexpression of IRS-1 resulted in inhibition of basal autophagy, and reduced oxidative stress-induced autophagy and cell death. ROS decreased the mammalian target of rapamycin (mTOR)/p70 ribosomal protein S6 kinase signaling, while overexpression of IRS-1 attenuated this inhibition. Knockdown of autophagy-related gene 5 inhibited basal autophagy and diminished oxidative stress-induced autophagy and cell death. Conclusion: Our results suggest that overexpression of IRS-1 promotes cells growth, inhibits basal autophagy, reduces oxidative stress-induced autophagy, and diminishes oxidative stress-mediated autophagy-dependent cell death. ROS-mediated autophagy may occur via inhibition of IRS-1/phosphatidylinositol 3-kinase/mTOR signaling. Our data afford a plausible explanation for IRS-1 involvement in tumor initiation and progression.

1 May 2020 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
KTKun-Ling Tsai
Kun-Ling Tsai
PHPei-Ling Hsieh
Pei-Ling Hsieh
WCWan-Ching Chou
Wan-Ching Chou
CHChing-Hsia Hung
Ching-Hsia Hung
HYHsin-Lun Yang
Hsin-Lun Yang
KTKun-Ling Tsai
Kun-Ling Tsai

1 January 2012 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
KTKun-Ling Tsai
Kun-Ling Tsai
JCJyh-Hong Chen
Jyh-Hong Chen
YLYi-Heng Li
Yi-Heng Li
LTLiang-Miin Tsai
Liang-Miin Tsai
Gly1057Asp polymorphism in insulin receptor substrate (IRS)-2 is related to insulin resistance and diabetes mellitus (DM), which both contribute to the pathogenesis of coronary artery disease (CAD). Hence, we hypothesize that Gly1057Asp polymorphism in IRS-2 is associated with CAD.